Fix: Start with 2030 mcg/day and assess tolerance over 12 weeks
European Journal of Applied Physiology and Occupational Physiology, 61(5-6), 486490
Unlike BPC-157, youre not relying on a synthetic substance that might not work the same way in humans as it does in animals
Disclosure of interest: Pier Andrea Rizzo: nothing to disclose Poster Session II - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.01 - PATHOPHYSIOLOGY OF STROKE / TRANSLATIONAL MEDICINE P1074 - ESOC25-2189 ACTIVATED LEUCOCYTE CELL ADHESION MOLECULE IN MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION Alejandro Rodrguez Vzquez 1,2,3 , Andrea Cabero-Arnold 1,2 , Carlos Laredo 1,2 , Monica Serrano 1 , Yolanda Gonzlez Romero 1 , Antonio Doncel-Moriano 1 , Salvatore Rudilosso, Sergio Amaro, Arturo Ren 1 , Laura Llull, Angel Chamorro 1 , Francisco Lozano 2,4 , Xabier Urra 1 1 Comprehensive Stroke Center, Hospital Clnic de Barcelona, Barcelona, Spain, 2 Fundaci de Recerca Clnic Barcelona - Institut d'Investigacins Biomdiques August Pi i Sunyer, Barcelona, Spain, 3 Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain, 4 Centre de Diagnstic Biomdic, Hospital Clnic de Barcelona, Barcelona, Spain Background and Aims: Malignant cerebral infarction (MCI) is a devastating situation with no effective treatment besides hemicraniectomy
Julian Vyas, Sailesh Kotecha
We welcome the fact that weve got until October to deal with this issue and were hopeful that by the end of this year, the supply of manufactured products will catch up with demand. Cut through the noise of federal politics with news, views and expert analysis
